A Win For Cleveland BioLabs, Inc.

Mon 13 Jan 20 at 05:30 PM
A Win For Cleveland BioLabs, Inc.

Cleveland BioLabs, Inc. (CBLI:NASDAQ) shot up at $0.95, representing a gain of 46.2%. On Fri 10 Jan 20, CBLI:NASDAQ hit a New 2-Week Intraday High of $0.68. From Thu 19 Dec 19, the stock recorded 42.86% Up Days and 40.00% Green Days

The stock spiked on Tue 26 Nov 19 at $1.19 with a volume of 1M+, and its share price has been moving sideways in recent weeks.

About Cleveland BioLabs, Inc. (CBLI:NASDAQ)

Cleveland BioLabs Inc is a biopharmaceutical company developing novel approaches to activate immune system & address medical needs. Its proprietary platform of toll-like immune receptor activators are used in radiation, oncology immunotherapy & vaccine.